GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Connect Biopharma Holdings Ltd (NAS:CNTB) » Definitions » Other Operating Expense

Connect Biopharma Holdings (Connect Biopharma Holdings) Other Operating Expense : $-1.58 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Connect Biopharma Holdings Other Operating Expense?

Connect Biopharma Holdings's Other Operating Expense for the six months ended in Dec. 2023 was $-0.19 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.58 Mil.

Connect Biopharma Holdings's quarterly Other Operating Expense declined from Dec. 2022 ($-0.69 Mil) to Jun. 2023 ($-1.39 Mil) but then increased from Jun. 2023 ($-1.39 Mil) to Dec. 2023 ($-0.19 Mil).

Connect Biopharma Holdings's annual Other Operating Expense increased from Dec. 2021 ($-2.95 Mil) to Dec. 2022 ($-0.93 Mil) but then declined from Dec. 2022 ($-0.93 Mil) to Dec. 2023 ($-1.58 Mil).


Connect Biopharma Holdings Other Operating Expense Historical Data

The historical data trend for Connect Biopharma Holdings's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Connect Biopharma Holdings Other Operating Expense Chart

Connect Biopharma Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
-0.40 -1.07 -2.95 -0.93 -1.58

Connect Biopharma Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only -2.17 -0.24 -0.69 -1.39 -0.19

Connect Biopharma Holdings Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-1.58 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Connect Biopharma Holdings Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Connect Biopharma Holdings's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Connect Biopharma Holdings (Connect Biopharma Holdings) Business Description

Traded in Other Exchanges
N/A
Address
12265 El Camino Real, Suite 350, San Diego, CA, USA, 92130
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.